Yahoo Web Search

Search results

    • Pfizer plans for oral obesity drug hit new setback

      Pfizer plans for oral obesity drug hit new setback

      BioPharma Dive via Yahoo Finance· 5 months ago

      The company won’t continue development of a twice-daily dose of its experimental weight loss medicine danuglipron after study data showed high rates of...